Search
for
Sort by
Research 121–150 of 1000+
- The investigation and management of hirsutism
- Endocannabinoid activation and polycystic ovary syndrome: A systematic review
- MANAGEMENT OF HIRSUTISM
- Mini Review on Polycystic Ovary Syndrome (PCOS)
- New onset of alopecia in a young woman with end-stage renal disease
- Polycystic Ovary Syndrome
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Hirsutism: Evaluation and treatment
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Polycystic ovarian syndrome
- Idiopathic hirsutism: excessive bodily and facial hair in women
- Pharmacological management of polycystic ovary syndrome
- Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism
- Hirsutism-A Comprehensive Update of Embryology, Aetiopathogenesis and Therapeutic Approach
- CURRENT THERAPEUTIC APPROACHES IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME
- SÍNDROME DOS OVÁRIOS POLICÍSTICOS E MANIFESTAÇÕES DERMATOLÓGICAS: DO DIAGNÓSTICO À TERAPÊUTICA ESTÉTICA
- What should be kept in mind when treating acne with oral contraceptives? Narrative review
- Polycystic Ovary Syndrome: Current Insights Into Etiology, Symptoms, And Treatment Options
- Contemplation on Polycystic Ovarian Syndrome
- Polycystic ovarian disease in adult and perimenopausal women
- [Dermatologic indications for anti-androgenic treatment].
- Androgen effects on the skin
- Health benefits of hormonal contraception used by symptoms associated with acne vulgaris and hirsutism
- Hormonal Control of Cardiac Action Potential Phase 1 Currents in the Brugada Syndrome
- The effects of pro-, pre- and synbiotics supplementation on polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials
- Gender-Affirming Hormonal Treatment in Transgender People Assigned Female at Birth (AFAB)
- Management OF Patients with Polycystic Ovary Syndrom
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- The Hirsute Woman: Challenges in Evaluation and Management